Lynch & Associates’s Amgen AMGN Stock Holding History

Lynch & Associates’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.35M	Buy	6,491 +139	+2%	+$47.6K	0.41%	63
2026 Q1	$2.23M	Buy	6,352 +109	+2%	+$38.9K	0.42%	60
2025 Q4	$2.04M	Buy	6,243 +1,032	+20%	+$327K	0.39%	58
2025 Q3	$1.47M	Buy	5,211 +17	+0.3%	+$4.93K	0.28%	69
2025 Q2	$1.45M	Buy	5,194 +52	+1%	+$14.7K	0.29%	69
2025 Q1	$1.6M	Sell	5,142 -12	-0.2%	-$3.54K	0.35%	65
2024 Q4	$1.34M	Sell	5,154 -171	-3%	-$50.7K	0.29%	66
2024 Q3	$1.72M	Buy	5,325 +345	+7%	+$113K	0.36%	63
2024 Q2	$1.56M	Buy	4,980 +386	+8%	+$113K	0.35%	63
2024 Q1	$1.31M	Buy	4,594 +1,055	+30%	+$309K	0.3%	68
2023 Q4	$1.02M	Buy	3,539 +2,582	+270%	+$704K	0.25%	70
2023 Q3	$257K	Buy	+957	New	+$239K	0.07%	100

Other funds holding AMGN

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Lynch & Associates's AMGN Position: Q2 2026 in Review

Lynch & Associates increased its Amgen (AMGN) stake by 2.2% in Q2 2026, buying an estimated $47.6K and bringing the position to 6,491 shares worth $2.35M. The position accounts for 0.41% of the portfolio, ranked #63.

Lynch & Associates first reported a position in AMGN in Q3 2023 and has held it in 12 quarters since. 1,543 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

Lynch & Associates held 6,491 shares of Amgen worth $2.35M as of Q2 2026.
Lynch & Associates bought 139 Amgen shares in Q2 2026, an estimated $47.6K.
Amgen made up 0.41% of Lynch & Associates's portfolio in Q2 2026, its #63 holding.
Lynch & Associates first reported a position in Amgen in Q3 2023 and has held it in 12 quarters since.
1,543 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Lynch & Associates's 13F filing for Q2 2026, filed 13 Jul 2026.